Petra Hrubá

888 total citations
53 papers, 469 citations indexed

About

Petra Hrubá is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Petra Hrubá has authored 53 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Transplantation, 20 papers in Surgery and 16 papers in Nephrology. Recurrent topics in Petra Hrubá's work include Renal Transplantation Outcomes and Treatments (40 papers), Organ Transplantation Techniques and Outcomes (13 papers) and Cytomegalovirus and herpesvirus research (12 papers). Petra Hrubá is often cited by papers focused on Renal Transplantation Outcomes and Treatments (40 papers), Organ Transplantation Techniques and Outcomes (13 papers) and Cytomegalovirus and herpesvirus research (12 papers). Petra Hrubá collaborates with scholars based in Czechia, Germany and Canada. Petra Hrubá's co-authors include Ondřej Viklický, J. Tupý, Janka Slatinská, David Honys, David Twell, Věra Čapková, Eva Honsová, Jana Malušková, Zdeněk Krejčík and Alena Sekerková and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Petra Hrubá

49 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Hrubá Czechia 12 243 125 100 100 97 53 469
Petra Hřibová Czechia 13 242 1.0× 136 1.1× 115 1.1× 112 1.1× 49 0.5× 21 451
James H. Lan Canada 10 226 0.9× 171 1.4× 46 0.5× 77 0.8× 52 0.5× 36 391
Victoria Rodríguez United States 6 186 0.8× 116 0.9× 73 0.7× 66 0.7× 14 0.1× 9 439
Matthias Strobl Germany 9 33 0.1× 78 0.6× 19 0.2× 79 0.8× 53 0.5× 11 422
Kelly E. Lake United States 9 60 0.2× 27 0.2× 33 0.3× 114 1.1× 46 0.5× 31 371
Mohammad Amin Abbasi Iran 11 97 0.4× 88 0.7× 55 0.6× 45 0.5× 10 0.1× 41 308
Niloufar Kossari France 8 114 0.5× 138 1.1× 70 0.7× 53 0.5× 40 0.4× 9 319
Morten Buus Jørgensen Denmark 13 28 0.1× 171 1.4× 77 0.8× 152 1.5× 25 0.3× 29 616
Kamala Balakrishnan United States 12 33 0.1× 86 0.7× 61 0.6× 108 1.1× 47 0.5× 26 434
Stephan R. Lederer Germany 10 247 1.0× 167 1.3× 54 0.5× 146 1.5× 127 1.3× 22 447

Countries citing papers authored by Petra Hrubá

Since Specialization
Citations

This map shows the geographic impact of Petra Hrubá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Hrubá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Hrubá more than expected).

Fields of papers citing papers by Petra Hrubá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Hrubá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Hrubá. The network helps show where Petra Hrubá may publish in the future.

Co-authorship network of co-authors of Petra Hrubá

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Hrubá. A scholar is included among the top collaborators of Petra Hrubá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Hrubá. Petra Hrubá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hrubá, Petra, Jǐŕı Kléma, Luděk Voska, et al.. (2024). Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation. Transplantation Direct. 11(1). e1741–e1741.
3.
Mjøen, Geir, et al.. (2023). A novel prognostic nomogram predicts premature failure of kidney allografts with IgA nephropathy recurrence. Nephrology Dialysis Transplantation. 38(11). 2627–2636. 3 indexed citations
4.
Vaňková, Hana, et al.. (2023). The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients. International Urology and Nephrology. 55(11). 2959–2965. 1 indexed citations
5.
Hubáček, Jaroslav A., Petra Hrubá, Věra Adámková, Eva Pokorná, & Ondřej Viklický. (2022). Apolipoprotein L1 variability is associated with increased risk of renal failure in the Czech population. Gene. 818. 146248–146248. 1 indexed citations
6.
Viklický, Ondřej, et al.. (2022). Sepsis affects kidney graft function and one-year mortality of the recipients in contrast with systemic inflammatory response. Frontiers in Medicine. 9. 923524–923524. 3 indexed citations
7.
Cahová, Monika, et al.. (2021). Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors. Kidney & Blood Pressure Research. 46(2). 245–249. 4 indexed citations
8.
Maixnerová, Dita, Petra Hrubá, Michaela Neprašová, et al.. (2021). Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation. Frontiers in Immunology. 12. 726215–726215. 9 indexed citations
9.
Hrubá, Petra, Luděk Voska, Eva Sticová, et al.. (2021). Chronic Active Antibody-Mediated Rejection Is Associated With the Upregulation of Interstitial But Not Glomerular Transcripts. Frontiers in Immunology. 12. 729558–729558. 7 indexed citations
10.
Hrubá, Petra, et al.. (2021). Intimal Arteritis and Microvascular Inflammation Are Associated With Inferior Kidney Graft Outcome, Regardless of Donor-Specific Antibodies. Frontiers in Medicine. 8. 781206–781206. 3 indexed citations
11.
Hrubá, Petra, Zdeněk Krejčík, Michaela Dostálová Merkerová, et al.. (2020). Molecular Fingerprints of Borderline Changes in Kidney Allografts Are Influenced by Donor Category. Frontiers in Immunology. 11. 423–423. 6 indexed citations
12.
Hrubá, Petra, Janka Slatinská, Birgit Sawitzki, et al.. (2020). Dialysis therapy is associated with peripheral marginal zone B-cell augmentation. Transplant Immunology. 60. 101289–101289. 1 indexed citations
13.
Hrubá, Petra, et al.. (2020). Molecular assessment of kidney allografts: are we closer to a daily routine?. Physiological Research. 69(2). 215–226. 4 indexed citations
14.
Reischig, Tomáš, Martin Kacer, Petra Hrubá, et al.. (2018). Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial. BMC Infectious Diseases. 18(1). 573–573. 17 indexed citations
15.
Hrubá, Petra, et al.. (2018). Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation. Frontiers in Immunology. 9. 2310–2310. 17 indexed citations
16.
Hrubá, Petra, Dita Maixnerová, Roman Zachoval, et al.. (2018). Molecular Profiling in IgA Nephropathy and Focal and Segmental Glomerulosclerosis. Physiological Research. 67(1). 93–105. 23 indexed citations
17.
Hrubá, Petra, Alena Sekerková, Janka Slatinská, et al.. (2017). Steroid free immunosuppression is associated with enhanced Th1 transcripts in kidney transplantation. Transplant Immunology. 42. 18–23. 5 indexed citations
18.
Viklický, Ondřej, Petra Hrubá, Stefan Tomiuk, et al.. (2017). Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial. PLoS ONE. 12(1). e0169624–e0169624. 9 indexed citations
19.
Hrubá, Petra, et al.. (2015). Circulating biomarkers of tolerance. Transplantation Reviews. 29(2). 68–72. 11 indexed citations
20.
Hrubá, Petra, David Honys, David Twell, Věra Čapková, & J. Tupý. (2004). Expression of β-galactosidase and β-xylosidase genes during microspore and pollen development. Planta. 220(6). 931–940. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026